Personalized pathway enrichment map of putative cancer genes from next generation sequencing data

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Jia, Peilin ^a   Zhao, Zhongming ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EFGR GENE; GENE; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GLIOBLASTOMA; GLIOMA; INTERMETHOD COMPARISON; LUNG CANCER; LUNG NON SMALL CELL CANCER; MELANOMA; MUTATION RATE; PANCREAS CANCER; PIK3R1 GENE; PTEN GENE; RB1 GENE; SEQUENCE DATABASE; STATISTICAL ANALYSIS; TP53 GENE; TUMOR GENE; DNA SEQUENCE; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; METHODOLOGY;

GENES, NEOPLASM; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION RATE; SEQUENCE ANALYSIS, DNA;

EID: 84862095836     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037595     Document Type: Article

References (25)

1. Ladanyi M, Pao W, (2008) Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Mod Pathol 21 (Suppl 2): S16-22.
2. Yamamoto H, Shigematsu H, Nomura M, Lockwood WW, Sato M, et al. (2008) PIK3CA mutations and copy number gains in human lung cancers. Cancer Res 68: 6913-6921.
3. The Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
4. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, et al. (2010) The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465: 473-477.
5. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
6. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
7. Wendl MC, Wallis JW, Lin L, Kandoth C, Mardis ER, et al. (2011) PathScan: a tool for discerning mutational significance in groups of putative cancer genes. Bioinformatics 27: 1595-1602.
8. Young MD, Wakefield MJ, Smyth GK, Oshlack A, (2010) Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11: R14.
9. Gu Y, Zhao W, Xia J, Zhang Y, Wu R, et al. (2011) Analysis of pathway mutation profiles highlights collaboration between cancer-associated superpathways. Hum Mutat 32: 1028-1035.
10. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M, (2011) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40: D109-114.
11. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
12. Getz G, Hofling H, Mesirov JP, Golub TR, Meyerson M, et al. (2007) Comment on "The consensus coding sequences of human breast and colorectal cancers". Science 317: 1500.
13. Forrest WF, Cavet G, (2007) Comment on "The consensus coding sequences of human breast and colorectal cancers". Science 317: 1500; author reply 1500.
14. Rubin AF, Green P, (2007) Comment on "The consensus coding sequences of human breast and colorectal cancers". Science 317: 1500.
15. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
16. Merico D, Isserlin R, Stueker O, Emili A, Bader GD, (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5: e13984.
17. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, et al. (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466: 368-372.
18. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
19. Ramanan VK, Shen L, Moore JH, Saykin AJ, (2012) Pathway analysis of genomic data: concepts, methods and prospects for future development. Trends Genet doi:10.1016/j.tig.2012.03.004.
20. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
21. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
22. Gojobori T, Li WH, Graur D, (1982) Patterns of nucleotide substitution in pseudogenes and functional genes. J Mol Evol 18: 360-369.
23. Zhao Z, Fu YX, Hewett-Emmett D, Boerwinkle E, (2003) Investigating single nucleotide polymorphism (SNP) density in the human genome and its implications for molecular evolution. Gene 312: 207-213.
24. Xia J, Wang Q, Jia P, Wang B, Pao W, et al. (2012) NGS Catalog: A database of next generation sequencing studies in humans. Hum Mutat doi:2010.1002/humu.22096.
25. Raychaudhuri S, Korn JM, McCarroll SA, Altshuler D, Sklar P, et al. (2010) Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet 6: e1001097.